市場資訊

Cassava Sciences, Inc. (SAVA)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimera€ s disease, including PTI-125 and PTI-125Dx. The company was founded by